ANGO - Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today? | Benzinga
AngioDynamics Inc (NASDAQ: ANGO) has reported a second-quarter (Q2) FY24 adjusted EPS loss of $(0.05), compared to the consensus of $(0.07) and EPS income of 1 cent reported a year ago.
Q2 sales increased 2.7% Y/Y to $79.1 million, missing the analyst consensus of $82.04 million, according to data from Benzinga Pro.
Med Tech net sales were $25.4 million, up 3.5% Y/Y, driven by Auryon sales of $11.4 million during the quarter, which increased 12.9%.
Med Device net sales were $53.7 million, up 2.3% Y/Y.
The gross ...